Veru Gross Margin 2010-2025 | VERU

Current and historical gross margin for Veru (VERU) over the last 10 years. The current gross profit margin for Veru as of March 31, 2025 is %.
Veru Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-06-30 $0.01B $0.00B 37.50%
2023-09-30 $0.02B $0.01B 47.06%
2023-06-30 $0.02B $0.01B 43.75%
2023-03-31 $0.02B $0.01B 56.52%
2022-12-31 $0.03B $0.02B 68.97%
2022-09-30 $0.04B $0.03B 77.50%
2022-06-30 $0.05B $0.04B 79.25%
2022-03-31 $0.06B $0.05B 80.33%
2021-12-31 $0.06B $0.05B 80.33%
2021-09-30 $0.06B $0.05B 77.42%
2021-06-30 $0.06B $0.05B 79.31%
2021-03-31 $0.05B $0.04B 78.00%
2020-12-31 $0.05B $0.04B 74.47%
2020-09-30 $0.04B $0.03B 72.09%
2020-06-30 $0.04B $0.03B 67.50%
2020-03-31 $0.04B $0.03B 67.50%
2019-12-31 $0.04B $0.03B 67.57%
2019-09-30 $0.03B $0.02B 71.88%
2019-06-30 $0.03B $0.02B 71.43%
2019-03-31 $0.02B $0.02B 66.67%
2018-12-31 $0.02B $0.01B 60.00%
2018-09-30 $0.02B $0.01B 47.06%
2018-06-30 $0.02B $0.01B 43.75%
2018-03-31 $0.01B $0.01B 42.86%
2017-12-31 $0.01B $0.01B 46.15%
2017-09-30 $0.01B $0.01B 53.85%
2017-06-30 $0.01B $0.01B 53.85%
2017-03-31 $0.02B $0.01B 53.33%
2016-12-31 $0.02B $0.01B 55.56%
2016-09-30 $0.02B $0.01B 56.52%
2016-06-30 $0.03B $0.02B 57.69%
2016-03-31 $0.03B $0.02B 60.71%
2015-12-31 $0.03B $0.02B 58.82%
2015-09-30 $0.03B $0.02B 57.58%
2015-06-30 $0.03B $0.02B 56.25%
2015-03-31 $0.03B $0.02B 53.13%
2014-12-31 $0.03B $0.01B 52.00%
2014-09-30 $0.03B $0.01B 52.00%
2014-06-30 $0.02B $0.01B 50.00%
2014-03-31 $0.02B $0.01B 52.17%
2013-12-31 $0.03B $0.02B 57.14%
2013-09-30 $0.03B $0.02B 58.06%
2013-06-30 $0.04B $0.02B 61.11%
2013-03-31 $0.04B $0.02B 60.53%
2012-12-31 $0.04B $0.02B 59.46%
2012-09-30 $0.04B $0.02B 58.33%
2012-06-30 $0.03B $0.02B 57.58%
2012-03-31 $0.03B $0.02B 57.14%
2011-12-31 $0.02B $0.01B 54.17%
2011-09-30 $0.02B $0.01B 52.63%
2011-06-30 $0.02B $0.01B 55.00%
2011-03-31 $0.02B $0.01B 55.56%
2010-12-31 $0.02B $0.01B 57.14%
2010-09-30 $0.02B $0.01B 59.09%
2010-06-30 $0.02B $0.01B 54.55%
2010-03-31 $0.03B $0.01B 51.85%
2009-12-31 $0.03B $0.01B 51.85%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.091B $0.017B
Veru Inc. engages in the development, manufacture and marketing of consumer health care products. It focuses on producing FC2 female condom which provides dual protection against unintended pregnancy and sexually transmitted infections. Veru Inc., formerly known as The Female Health Company, is headquartered in Miami, FL.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.381B 27.82
Boston Scientific (BSX) United States $149.868B 37.52
Stryker (SYK) United States $143.347B 29.97
EssilorLuxottica (ESLOY) France $128.152B 0.00
Medtronic (MDT) Ireland $110.735B 15.70
Lonza Group Ag (LZAGY) Switzerland $49.273B 0.00
Haleon (HLN) United Kingdom $46.835B 26.69
ResMed (RMD) United States $37.196B 27.94
Agilent Technologies (A) United States $32.827B 21.40
GE HealthCare Technologies (GEHC) United States $32.638B 15.50
Terumo (TRUMY) Japan $26.398B 34.29
Koninklijke Philips (PHG) Netherlands $21.463B 15.06
Insulet (PODD) United States $21.334B 83.74
Zimmer Biomet Holdings (ZBH) United States $18.048B 11.59
Baxter (BAX) United States $15.390B 11.49
Smith & Nephew SNATS (SNN) United Kingdom $12.627B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.442B 22.42
Lantheus Holdings (LNTH) United States $5.479B 13.82
Prestige Consumer Healthcare (PBH) United States $4.123B 18.42
Perrigo (PRGO) Ireland $3.643B 9.23
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.415B 15.55
Envista Holdings (NVST) United States $3.202B 26.61
ICU Medical (ICUI) United States $3.144B 23.18
QuidelOrtho (QDEL) United States $1.896B 13.04
LeMaitre Vascular (LMAT) United States $1.848B 41.30
AtriCure (ATRC) United States $1.554B 0.00
Acuren (TIC) United States $1.324B 0.00
AdaptHealth (AHCO) United States $1.132B 11.49
Neogen (NEOG) United States $1.072B 13.72
Green Thumb Industries (GTBIF) United States $1.042B 23.43
BioLife Solutions (BLFS) United States $1.008B 0.00
Phibro Animal Health (PAHC) United States $0.968B 12.37
InMode (INMD) Israel $0.839B 8.46
Kestra Medical Technologies (KMTS) United States $0.772B 0.00
CeriBell (CBLL) United States $0.647B 0.00
Evolus (EOLS) United States $0.598B 0.00
Owens & Minor (OMI) United States $0.567B 4.71
Curaleaf Holdings (CURLF) Canada $0.531B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.525B 0.00
Valneva SE (VALN) France $0.478B 0.00
Surmodics (SRDX) United States $0.415B 0.00
Capricor Therapeutics (CAPR) United States $0.377B 0.00
Tilray Brands (TLRY) Canada $0.362B 0.00
SNDL (SNDL) Canada $0.328B 0.00
VAREX IMAGING (VREX) United States $0.319B 11.74
SEMPERIT AG HLD (SEIGY) Austria $0.307B 0.00
Sanuwave Health (SNWV) United States $0.288B 0.00
Viemed Healthcare (VMD) United States $0.262B 22.07
Cerus (CERS) United States $0.256B 0.00
ZimVie (ZIMV) United States $0.245B 11.13
Sanara MedTech (SMTI) United States $0.242B 0.00
Quanterix (QTRX) United States $0.238B 0.00
Aurora Cannabis (ACB) Canada $0.229B 68.00
Canopy Growth (CGC) Canada $0.228B 0.00
OraSure Technologies (OSUR) United States $0.224B 0.00
Biote (BTMD) United States $0.217B 6.09
Cresco Labs (CRLBF) United States $0.212B 0.00
TriSalus Life Sciences (TLSI) United States $0.212B 0.00
Brainsway (BWAY) Israel $0.206B 54.55
Omeros (OMER) United States $0.188B 0.00
High Tide (HITI) Canada $0.180B 0.00
Utah Medical Products (UTMD) United States $0.174B 14.19
Verano Holdings (VRNOF) United States $0.174B 0.00
Organigram Global (OGI) Canada $0.173B 0.00
Exagen (XGN) United States $0.154B 0.00
Vireo Growth (VREOF) United States $0.132B 0.00
FitLife Brands (FTLF) United States $0.125B 15.40
Jin Medical (ZJYL) China $0.095B 0.00
Fonar (FONR) United States $0.088B 11.34
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Quipt Home Medical (QIPT) United States $0.083B 0.00
MacroGenics (MGNX) United States $0.083B 0.00
Agape ATP (ATPC) $0.079B 0.00
TerrAscend (TSNDF) Canada $0.077B 0.00
Apyx Medical (APYX) United States $0.076B 0.00
Zynex (ZYXI) United States $0.075B 0.00
Cytosorbents (CTSO) United States $0.074B 0.00
InterCure (INCR) Israel $0.069B 0.00
ImmuCell (ICCC) United States $0.069B 0.00
Jushi Holdings (JUSHF) United States $0.054B 0.00
Nephros (NEPH) United States $0.053B 71.43
Modular Medical (MODD) United States $0.041B 0.00
United-Guardian (UG) United States $0.038B 12.98
Rockwell Medical (RMTI) United States $0.030B 0.00
Safety Shot (SHOT) United States $0.023B 0.00
INLIF (INLF) $0.019B 0.00
Allurion Technologies (ALUR) United States $0.017B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.011B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00